These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3995112)

  • 1. Cognitive functioning in biological subtypes of depression.
    Silberman EK; Weingartner H; Targum SD; Byrnes S
    Biol Psychiatry; 1985 Jun; 20(6):654-61. PubMed ID: 3995112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DST abnormality as a predictor of course in major depression.
    Coryell W
    J Affect Disord; 1990 Jul; 19(3):163-9. PubMed ID: 2145336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of concurrent medical illness on dexamethasone suppression test results in depressed inpatients.
    Cooke RG; Warsh JJ; Stancer HC; Hasey GM; Jorna T; Langlet F
    Can J Psychiatry; 1990 Feb; 35(1):31-5. PubMed ID: 2317731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptom profile of patients with positive DST: a pilot study.
    Nasr SJ; Pandey G; Altman EG; Gibbons R; Gaviria FM; Davis JM
    Biol Psychiatry; 1983 May; 18(5):571-4. PubMed ID: 6860729
    [No Abstract]   [Full Text] [Related]  

  • 5. Dexamethasone suppression test results in delusional versus nondelusional depression: preliminary evidence of distinct clinical entities.
    Kraus RP; Remick RA
    J Clin Psychiatry; 1985 May; 46(5):188-90. PubMed ID: 3988719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dexamethasone suppression test and the Children's Depression Inventory in psychiatric disorders in children.
    Woodside DB; Brownstone D; Fisman S
    Can J Psychiatry; 1987 Feb; 32(1):2-4. PubMed ID: 3815250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An American validation study of the Newcastle diagnostic scale. I. Relationship with the dexamethasone suppression test.
    Zimmerman M; Pfohl B; Stangl D; Coryell W
    Br J Psychiatry; 1986 Nov; 149():627-30. PubMed ID: 3814955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four definitions of endogenous depression and the dexamethasone suppression test.
    Zimmerman M; Coryell W; Pfohl B; Stangl D
    J Affect Disord; 1985; 8(1):37-45. PubMed ID: 3156910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can disulfiram potentiate the dexamethasone suppression test in depressive patients?
    Bergsholm P; Oulie D; Holsten F; Myking O
    J Affect Disord; 1993 Aug; 28(4):241-7. PubMed ID: 8227760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone suppression test status and severity of depression.
    Meador-Woodruff JH; Greden JF; Grunhaus L; Haskett RF
    Biol Psychiatry; 1988 Oct; 24(6):693-6. PubMed ID: 3167151
    [No Abstract]   [Full Text] [Related]  

  • 11. [Deficits in memory retrieval: an argument in favor of frontal subcortical dysfunction in depression].
    Fossati P; Deweer B; Raoux N; Allilaire JF
    Encephale; 1995; 21(4):295-305. PubMed ID: 7588169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma dexamethasone concentrations and differential suppression response of cortisol and corticosterone in depressives and controls.
    Holsboer F; Haack D; Gerken A; Vecsei P
    Biol Psychiatry; 1984 Mar; 19(3):281-91. PubMed ID: 6722226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone suppression test, TRH test and Newcastle II depression rating in the diagnosis of depressive disorders.
    Larsen JK; Bjørum N; Kirkegaard C; Aggernaes H; Krog-Meyer I; Lund-Laursen AM; Mikkelsen PL
    Acta Psychiatr Scand; 1985 May; 71(5):499-505. PubMed ID: 3925727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Weissenburger JE; Fulton CL; Fairchild CJ; Roffwarg HP
    Biol Psychiatry; 1997 May; 41(9):915-28. PubMed ID: 9110097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone suppression test in depression with reversible dementia.
    Alexopoulos GS; Young RC; Haycox JA; Shamoian CA; Blass JP
    Psychiatry Res; 1985 Dec; 16(4):277-85. PubMed ID: 4089057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic heterogeneity and the DST in consecutive psychiatric admissions.
    Keitner GI; Haier RJ; Qualls CB; Brown WA; McKendall MJ
    Psychiatry Res; 1985 Mar; 14(3):215-23. PubMed ID: 3858894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the dexamethasone suppression test relate to subtypes, factors, symptoms, or severity?
    Miller KB; Nelson JC
    Arch Gen Psychiatry; 1987 Sep; 44(9):769-74. PubMed ID: 3632250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dexamethasone suppression test and quantitative cerebral anatomy in depression.
    Coffey CE; Wilkinson WE; Weiner RD; Ritchie JC; Aque M
    Biol Psychiatry; 1993 Mar; 33(6):442-9. PubMed ID: 8490071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial dexamethasone suppression tests in initial suppressors and nonsuppressors treated with electroconvulsive therapy.
    Devanand DP; Decina P; Sackeim HA; Hopkins N; Novacenko H; Malitz S
    Biol Psychiatry; 1987 Apr; 22(4):463-72. PubMed ID: 3567261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of the dexamethasone test in the differential diagnosis of depressive states].
    Nuller IuL; Ostroumova MN; Gordon OI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(4):547-51. PubMed ID: 3716705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.